Page last updated: 2024-10-31

mitoxantrone and Hepatitis C

mitoxantrone has been researched along with Hepatitis C in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, JW1
Chang, ML1
Hsu, CW1
Chen, YC1
Liang, KH1
Huang, YH1
Lin, CC1
Yeh, CT1

Other Studies

1 other study available for mitoxantrone and Hepatitis C

ArticleYear
Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.
    Journal of medical virology, 2017, Volume: 89, Issue:1

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Cisplatin; Drug Therapy; Female; Fluorouraci

2017